HLA-DR (LA) IMMUNE PHENOTYPE PREDICTS OUTCOME FOR PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA

被引：81

作者：

MILLER, TP

LIPPMAN, SM

SPIER, CM

SLYMEN, DJ

GROGAN, TM

机构：

[1] UNIV ARIZONA,DEPT MED,TUCSON,AZ 85724

[2] UNIV ARIZONA,DEPT PATHOL,TUCSON,AZ 85724

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1988年 / 82卷 / 01期

关键词：

D O I：

10.1172/JCI113598

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：370 / 372

页数：3

共 22 条

[1]

[Anonymous], 1982, CANCER, V49, P2112

[2] CLINICAL AND IMMUNOLOGICAL STUDY OF NON-HODGKIN T-CELL LYMPHOMAS (CUTANEOUS AND LYMPHOBLASTIC LYMPHOMAS EXCLUDED) [J].

BROUET, JC ;

RABIAN, C ;

GISSELBRECHT, C ;

FLANDRIN, G .

BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (02) :315-327

[3]

CARBONE PP, 1971, CANCER RES, V31, P1860

[4]

CLAYBERGER C, 1987, LANCET, V2, P533

[5]

COLTMAN C A JR, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P197

[6]

COSSMAN J, 1984, CANCER, V54, P1310, DOI 10.1002/1097-0142(19841001)54:7<1310::AID-CNCR2820540714>3.0.CO

[7]

2-9

[8]

COX DR, 1984, ANAL SURVIVAL DATA, V0021

[9]

FISHER RI, 1987, SEMIN HEMATOL, V24, P21

[10]

GERDES J, 1987, LANCET, V2, P448

← 1 2 3 →